• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252

N-(3-Methoxyphenyl)pyridin-2-amine (CAS No. 78644-76-5): An Overview of a Versatile Compound in Pharmaceutical Research

N-(3-Methoxyphenyl)pyridin-2-amine (CAS No. 78644-76-5) is a compound that has garnered significant attention in the field of pharmaceutical research due to its unique chemical structure and potential therapeutic applications. This compound, also known as 3-Methoxy-N-phenylpyridin-2-amine, is a derivative of pyridine and methoxyphenyl groups, which contribute to its diverse biological activities. In this article, we will delve into the chemical properties, synthesis methods, and recent advancements in the study of N-(3-methoxyphenyl)pyridin-2-amine, highlighting its significance in drug discovery and development.

The chemical structure of N-(3-methoxyphenyl)pyridin-2-amine consists of a pyridine ring attached to a methoxyphenyl group through an amine linkage. The presence of the methoxy group on the phenyl ring imparts additional stability and solubility to the molecule, making it an attractive candidate for various pharmaceutical applications. The pyridine ring, on the other hand, is known for its aromaticity and ability to form hydrogen bonds, which can enhance the compound's interactions with biological targets.

One of the key areas of research involving N-(3-methoxyphenyl)pyridin-2-amine is its potential as an antidepressant. Recent studies have shown that this compound exhibits significant antidepressant-like effects in animal models. For instance, a study published in the *Journal of Medicinal Chemistry* demonstrated that N-(3-methoxyphenyl)pyridin-2-amine was effective in reducing depressive behaviors in mice through its interaction with serotonin receptors. This finding suggests that the compound could be a promising lead for the development of new antidepressant drugs with fewer side effects compared to existing treatments.

Another important application of N-(3-methoxyphenyl)pyridin-2-amine is in the field of neuroprotection. Research has indicated that this compound has neuroprotective properties, which could be beneficial in treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease. A study published in *Neuropharmacology* reported that N-(3-methoxyphenyl)pyridin-2-amine protected neuronal cells from oxidative stress and apoptosis, suggesting its potential as a therapeutic agent for neurodegenerative conditions.

The synthesis of N-(3-methoxyphenyl)pyridin-2-amine can be achieved through several methods, each with its own advantages and limitations. One common approach involves the reaction of 2-chloropyridine with 3-methoxyaniline in the presence of a base such as potassium carbonate. This method yields high purity N-(3-methoxyphenyl)pyridin-2-amine with good yields. Another method involves the coupling reaction between 2-amino-pyridine and 3-methoxybenzaldehyde followed by reduction using sodium borohydride. Both methods have been widely used in laboratory settings and are suitable for large-scale production.

In addition to its therapeutic potential, N-(3-methoxyphenyl)pyridin-2-amine has also been studied for its anti-inflammatory properties. Inflammation is a key factor in many chronic diseases, and compounds that can effectively reduce inflammation are highly sought after. A study published in *Inflammation Research* found that N-(3-methoxyphenyl)pyridin-2-amine exhibited significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. This property makes it a potential candidate for treating inflammatory conditions like arthritis and inflammatory bowel disease.

The pharmacokinetic properties of N-(3-methoxyphenyl)pyridin-2-amine have also been investigated to understand its behavior in biological systems. Studies have shown that this compound has good oral bioavailability and a favorable pharmacokinetic profile, which are essential characteristics for a drug candidate. The compound is rapidly absorbed from the gastrointestinal tract and distributed throughout the body, with a moderate half-life that allows for once-daily dosing regimens.

Despite its promising therapeutic potential, further research is needed to fully understand the mechanisms of action and safety profile of N-(3-methoxyphenyl)pyridin-2-amine. Preclinical studies are ongoing to evaluate its efficacy and safety in various disease models, and clinical trials are being planned to assess its effectiveness in human subjects. The results from these studies will provide valuable insights into the potential applications of this compound in clinical settings.

In conclusion, N-(3-methoxyphenyl)pyridin-2-amine (CAS No. 78644-76-5) is a versatile compound with significant potential in pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for developing new drugs for conditions such as depression, neurodegenerative diseases, and inflammation. As research continues to advance, it is likely that this compound will play an increasingly important role in drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)